Kuala lumpur: LAC Med Bhd, a medical devices and integrated solutions provider, is set to raise RM55.6 million from its initial public offering (IPO) ahead of its listing on the Main Market of Bursa Malaysia Securities Bhd scheduled for December 10, 2025. The company has outlined plans to utilize the funds for strengthening its domestic presence and expanding its operations into Indonesia.
According to BERNAMA News Agency, LAC Med Bhd intends to allocate RM8 million from the proceeds for its regional expansion into Indonesia. An additional RM12 million will be directed towards establishing a new head office and warehouse, which will include an expanded storage facility and showroom. The company has earmarked RM8 million for the development of two new business segments-equipment-as-a-service (EaaS) and medical devices asset management services (MEAMS). Moreover, RM16 million will be used for the repayment of bank borrowings, RM6.1 million for working capital, and the remaining RM5.5 million will cover listing expenses.
During the prospectus launch, LAC Med group CEO Liew Yoon Poh highlighted the company’s strategy of hiring local Indonesian talent to replicate its Malaysian success in Indonesia. He emphasized the importance of establishing a strong operational foundation with local expertise before pursuing rapid expansion. Liew also mentioned that the company’s asset management services would integrate artificial intelligence capabilities as part of its innovation roadmap.
The IPO will involve a total of 104.2 million ordinary shares at an issue price of 75 sen per share. This includes a public issue of 74.2 million new ordinary shares and an offer for sale of up to 30 million existing ordinary shares. Under the public issue, 50 million shares are designated for Bumiputera investors approved by the Ministry of Investment, Trade and Industry (MITI), 20 million shares will be available to the Malaysian public through balloting-with half reserved for Bumiputera investors-and 4.2 million shares will be allocated to eligible directors, employees, and contributors to the group’s success.
The offer for sale of 30 million shares will be directed towards institutional and selected investors via private placement. Upon listing, LAC Med’s enlarged share capital will consist of 400 million shares, with an indicative market capitalization of RM300 million. The public issue application opens today and will close at 5 pm on November 25, 2025. RHB Investment Bank Bhd is serving as the principal adviser, joint underwriter, and sole placement agent for the IPO, with Alliance Islamic Bank Bhd acting as the joint underwriter.